U. Arvidsson et al., THE KAPPA-OPIOID RECEPTOR IS PRIMARILY POSTSYNAPTIC - COMBINED IMMUNOHISTOCHEMICAL LOCALIZATION OF THE RECEPTOR AND ENDOGENOUS OPIOIDS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(11), 1995, pp. 5062-5066
Antisera were raised against a synthetic peptide corresponding to the
carboxyl terminus of the kappa-opioid receptor (KOR1). Specificity of
the antisera was verified by staining of COS-7 cells transfected with
KOR1 and epitope-tagged KOR1 cDNAs, by recognition by the antisera of
proteins on Western blots of both transfected cells and brain tissue,
by the absence of staining of both brain tissue and transfected cells
after preabsorption of the antisera with the cognate peptide, and on t
he strong correlation between the distribution of KOR1 immunoreactivit
y and that of earlier ligand binding and in situ hybridization studies
, Results indicate that KOR1 in neurons is targeted into both the axon
al and somatodendritic compartments, but the majority of immunostainin
g was seen in the somatodendritic compartment, In sections from rat an
d guinea pig brain, prominent KOR1 staining was seen in the ventral fo
rebrain, hypothalamus, thalamus, posterior pituitary, and midbrain. Wh
ile the staining pattern was similar in both species, distinct differe
nces were also observed. The distribution of preprodynorphin and KOR1
immunoreactivity was complementary in many brain regions, suggesting t
hat KOR1 is poised to mediate the physiological actions of dynorphin.
However, the distribution of KOR1 and enkephalin immunoreactivity was
complementary in some regions as well. These results suggest that the
KOR1 protein is primarily, but not exclusively, deployed to postsynapt
ic membranes where it mediates the effects of products of preprodynorp
hin and possibly preproenkephalin.